SCHEMBL30664715

SCHEMBL30664715

COC(=O)c1c(N(Cc2ccc(C(F)(F)F)cc2)C(C)=O)sc2cc(O)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 8/20 0.43
▸ PDK2 Q15119 1/20 0.40
▸ PDK4 Q16654 1/20 0.40
▸ ESR2 Q92731 1/20 0.38
▸ MAPK8 P45983 1/20 0.37
▸ MAPK10 P53779 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ TRPV1 Q8NER1 1/20 0.36
▸ CISD2 Q8N5K1 1/20 0.35
▸ BMP1 P13497 1/20 0.35
▸ LSS P48449 1/20 0.34
▸ ALOX5 P09917 1/20 0.34
▸ NLRP3 Q96P20 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ CRHBP P24387 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ CRHR2 Q13324 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24682171 1.00 ESR1 (0.43) ESR1PDK2PDK4ESR2MAPK8
SCHEMBL24683210 0.89 ESR1 (0.39) ESR1PDK2PDK4ESR2MAPT
SCHEMBL29799890 0.89 ESR1 (0.39) ESR1PDK2PDK4ESR2MAPT
SCHEMBL29799959 0.88 ESR1 (0.43) ESR1ESR2MAPTALOX5KDM4E
SCHEMBL24683189 0.88 ESR1 (0.43) ESR1ESR2MAPTALOX5KDM4E
SCHEMBL24682178 0.87 MAPT (0.43) ESR1ESR2MAPTTRPV1KDM4E
SCHEMBL29800041 0.87 MAPT (0.43) ESR1ESR2MAPTTRPV1KDM4E
SCHEMBL24682964 0.85 ESR1 (0.39) ESR1ESR2MAPTNLRP3MEN1
SCHEMBL30701715 0.85 ESR1 (0.39) ESR1ESR2MAPTNLRP3MEN1
SCHEMBL29799951 0.85 PDK2 (0.43) ESR1PDK2PDK4ESR2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 ESR1 4305/4885PDK2 593/4885PDK4 628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback